[O14] Oral Session 14　婦人科
【E】

[O14-2] Tisotumab Vedotin in Japanese Patients With Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 206 Study

^○米盛 勧¹, Yasutoshi Kuboki², Kosei Hasegawa³, Takashi Iwata⁴, Hidenori Kato⁵, Kazuhiro Takehara⁶, Yasuyuki Hirashima⁷, Hisamori Kato⁸, Chaitali Passey⁹, Jeppe Klint Buchbjerg¹⁰, Jeffrey R. Harris Harris⁹, Camilla Mondrup Andreassen¹⁰, Leonardo Nicacio¹¹, Ibrahima Soumaoro⁹, Keiichi Fujiwara³ (1.国立がん研究センター中央病院, 2.National Cancer Center Hospital East, 3.Saitama Medical University International Medical Center, 4.Keio University School of Medicine, 5.National Hospital Organization, Hokkaido Cancer Center, 6.NHO Shikoku Cancer Center, 7.Shizuoka Cancer Center, 8.Kanagawa Cancer Center, 9.Genmab US, Inc., 10.Genmab, 11.Seagen Inc.)